Zelira Therapeutics Ltd has released a press release.
Zelda expands its Intellectual Property portfolio
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Earlier from Zelira Therapeutics
- OpenBriefing Recording with Dr Stewart Washer
- Reinstatement to Official Quotation - 22 November 2016
- Suspension from Official Quotation
- Prospectus
- Consolidation/Split - GLN
Later from Zelira Therapeutics
- Significant Anti-Cancer Effect Observed in Studies
- Collaboration Agreement with Telethon Kids Institute
- Sleep Disorder Clinical Trials Update
- Zelda to Test Formulations Against Pancreatic Cancer
- Quarterly Report and Appendix 4C
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics